Citadel Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Sell |
|
|||||
|
2025
Q1 | $146K | Sell |
|
|||||
|
2024
Q4 | $5.03M | Sell |
|
|||||
|
2024
Q3 | $20.7M | Buy |
|
|||||
|
2024
Q2 | $10.6M | Buy |
|
|||||
|
2024
Q1 | $3.7M | Buy |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $548K | Sell |
|
|||||
|
2023
Q1 | $684K | Sell |
|
|||||
|
2022
Q4 | $2.65M | Sell |
|
|||||
|
2022
Q3 | $1.73M | Buy |
|
|||||
|
2022
Q2 | $1.88M | Buy |
|
|||||
|
2022
Q1 | $3.02M | Sell |
|
|||||
|
2021
Q4 | $5.05M | Buy |
|
|||||
|
2021
Q3 | $5.28M | Buy |
|
|||||
|
2021
Q2 | $3.69M | Buy |
|
|||||
|
2021
Q1 | $3.58M | Sell |
|
|||||
|
2020
Q4 | $3.69M | Sell |
|
|||||
|
2020
Q3 | $3.69M | Buy |
|